Brexit: How To Avoid UK Regulatory Divergence And Medicines Access Delays
Executive Summary
Health policy consultant Nick Fahy says that a much wider debate is needed on how to address the effects of Brexit in terms of possible regulatory divergence and reduced access to medicines in the UK, and suggests two ways forward.